Fig. 3From: Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)Example of a report. The report shows the classification of drugs in the three recommended categories, green (“use as directed”), yellow (“use with caution”), and red (“use with extreme caution”). The current AD (“1st drug”) is excluded from the list to avoid clinician bias in decision-makingBack to article page